New registry study to monitor ion beam therapy outcomes
NCT ID NCT03049072
First seen Mar 25, 2026 · Last updated May 07, 2026 · Updated 9 times
Summary
This study is a registry that collects information from about 2,800 tumor patients treated with ion beam therapy at MedAustron. The goal is to track treatment response, survival, side effects, and quality of life over time. No new treatment is being tested; instead, researchers are gathering real-world data to better understand how well this therapy works and its long-term effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ION BEAM RADIATION THERAPY FOR TUMOR PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
EBG MedAustron GmbH
RECRUITINGWiener Neustadt, Lower Austria, 2700, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.